Keryx's kidney drug meets main goals of mid-stage study

(Reuters) - Keryx Biopharmaceuticals Inc said its kidney drug met the main goals of a mid-stage study in patients with chronic kidney disease who were not on dialysis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news